US Supreme Court Declines To Review Case Concerning Whether A Biomarker Test Can Be Patented

Bloomberg (1/13, Decker) reports the US Supreme Court declined to take up “an appeal by Quest Diagnostics Inc. ‘s Athena unit that sought to restore its patent for a test to detect the presence of an autoimmune disease.” The article says that “a lower cou...